To investigate the hypothesis that reactive oxygen metabolites are important in the pathophysiology of duodenal ulcer disease, their production by duodenal mucosal biopsy specimens was measured using luminol and lucigenin amplified chemiluminescence. Luminol chemiluminescence, expressed as background corrected median photon emission/mg/min x 103 (95% confidence intervals), was increased in duodenal inflammation as assessed macroscopically: ulcers 20.3 (4.8 to 51.3), n=29; severe duodenitis 13.9 (6.6 to 75.3), n=16; mild duodenitis 0.0 (-0.5 to 0.8), n=56; controls -0.8 (-1.3 to -0.1), n=41; p=0.0001, Kruskal-Wallis) and microscopically: severe 17.0 (9.3 to 51.3), n=12; moderate 0.3 (-2.8 to 5.8), n=17; mild -0.1 (-1.8 to 1.0), n=17; controls -0*8 (-1.6 to 0.0), n=15; (p=0.0001). Luminol chemiluminescence was directly related to both the macroscopic and microscopic severity of duodenal damage (Spearman's R=+0.53, +0.55 respectively, both p=0.0001), to histochemical assessment (myeloperoxidase activity) of neutrophil infiltration (R= +0.63; p=0.04), and to lucigenin chemiluminescence (R=+0-56, p=0.0002). Luminol chemiluminescence was inhibited by sodium azide (-80%), catalase (-73%), and dimethyl sulphoxide (-24%). Superoxide dismutase inhibited lucigenin more than luminol dependent chemiluminescence (-61% and -7% respectively, p<0.05). Within disease groups, Helicobacter pylon antral infection was associated with increased duodenal chemiluminescence, whereas smoking, alcohol, and use ofNSAIDs or H2 blockers had no influence. Their disease related generation in duodenal mucosa supports a role for reactive oxygen metabolites in the pathogenesis of duodenitis and duodenal ulcer. These metabolites might include superoxide, hydrogen peroxide, hydroxyl, and products of myeloperoxidase activity. (Gut 1992; 33: 1467-1472 Reactive oxygen metabolite (ROM) production by inflammatory cells, while essential for survival, can be inappropriate or excessive, contributing more to host destruction than defence.' Increased ROM production has been linked to the pathogenesis of many inflammatory conditions, including those of the human gastrointestinal tract.2 Information directly linking ROM production with duodenal ulceration is mostly confined to animal models.34 One study to date, however, has shown ulcer healing in humans using scavengers or inhibitors of ROM production5; in addition, recent data suggest that the pathogenicity of Helicobacter pylori in the upper gastrointestinal tract might be related to stimulation of neutrophil ROM production.6
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EFFECT OF INHIBITORS

EFFECT OF H PYLORI AND OTHER RISK FACTORS
Antral H pylori infection was assessed in 89 patients (Table IV) . The increased chemiluminescence in the H pylon positive patients was not simply related to the increased likelihood of more severe duodenal damage than in those who were Hpylori negative. Biopsy samples from areas of similar inflammation produced significantly more chemiluminescence if antral H pylon infection coexisted: conversely, in the absence of duodenal damage antral H pylon status had no effect on the chemiluminescence result.
Luminol amplified chemiluminescence was not significantly different when the whole study group or disease subgroups were subdivided according to presence of the following risk factors for duodenal ulcer disease: smoking, high alcohol consumption (>30 U/week in men, >20 U/week in women) or use of NSAIDs: similarly, use of H2 blockers had no influence on the chemiluminescence result in any group (data not shown). Figure 3 shown as photonslmglminute after subtraction of background.
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The chemiluminescence assay we used to demonstrate the presence of mucosal ROMs is sensitive but non-specific. Although any oxidant may act as a substrate for the luminol or lucigenin chemiluminescence reactions, our results support the conclusion that chemiluminescence was produced by the interaction of ROMs with the chemiluminogenic probes. Firstly chemiluminescence correlates strongly with the degree of inflammatory cell infiltrate, whether assessed pathway products of arachidonic acid (results, however, conflicting in different animal models), by stimulating the release of platelet activating factor2' and activating the NF-kappaB transcription factor, which causes increased expression of genes coding for a range of proinflammatory mediators, including interleukin 6 and tumour necrosis factor a. 22 There was no evidence that smoking, alcohol, or use of NSAIDs affected mucosal ROM production within any disease group or m controls. Thus, while promoting duodenal mucosal injury and inflammation, these aetiological factors do not seem to stimulate neutrophils directly. Conversely, duodenal mucosal ROM production was considerably increased in patients positive for H pylon antral infection compared with those with similar macroscopic disease who were H pylori negative. H pylori have been shown to secrete chemotactic factors23 and to stimulate ROM production from human neutrophils in vitro." Our observations might be explained if H pylon derived chemoattractant and neutrophil stimulating factors had effects distant from the site of infection, or if they promoted neutrophil activation after infection of duodenal ectopic gastric mucosa.
In conclusion, we have shown evidence that duodenal mucosal ROM production is increased in duodenal ulceration and inflammation, particularly in the presence of antral H pylon infection. Our results suggest that antioxidants may contribute to the treatment and prophylaxis of duodenal ulcer disease.
